Insulin glargine and lixisenatide Subcutaneous and Xulane transdermal
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Xulane transdermal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: ethinyl estradiol / norelgestromin
Brand name: Xulane, Ortho Evra
Synonyms: Xulane (transdermal), Xulane
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Xultophy
- Insulin glargine and lixisenatide Subcutaneous-Xultophy 100/3.6
- Insulin glargine and lixisenatide Subcutaneous-Xuriden
- Insulin glargine and lixisenatide Subcutaneous-Xylocaine
- Insulin glargine and lixisenatide Subcutaneous-Xylocaine (Cardiac)
- Insulin glargine and lixisenatide Subcutaneous-Xylocaine (Lidocaine Injection Solution (Anesthetic))
- Xulane transdermal-Insulin glargine, recombinant Subcutaneous
- Xulane transdermal-Insulin glulisine
- Xulane transdermal-Insulin Glulisine (Cartridges and Pens)
- Xulane transdermal-Insulin Glulisine (Vials)
- Xulane transdermal-Insulin glulisine Subcutaneous
- Xulane transdermal-Insulin human inhaled Inhalation